Rybelsus Heartburn: How Common, How Long It Lasts
The Rybelsus label names dyspepsia as a reported side effect but gives no trial rate for it.
- In the label
- Listed, no rate given
- Label term
- dyspepsia
Rybelsus: key facts
Its half-life is about 1 week. After 7 d, half is gone, and about 3% remains after five half-lives (35 d).
In PIONEER 1, people with type 2 diabetes lost 3.7 kg over 26 weeks, compared with 1.4 kg on placebo.
Monthly prices in US dollars include list prices and self-pay offers, with each figure taken from the maker's price page.
Sources: FDA label (DailyMed), healthsystemtracker.org, Novo Nordisk pricing, Novo Nordisk.
What the Rybelsus label includes instead
The Rybelsus label does not give a rate for heartburn or indigestion. The five side effects reported most often in the label appear below, each with a rate.
| Side effect | Placebo | Rybelsus 7 mg | Rybelsus 14 mg | More than placebo, 14 mg |
|---|---|---|---|---|
| Nausea | 6% | 11% | 20% | +14 points |
| Abdominal Pain | 4% | 10% | 11% | +7 points |
| Diarrhea | 4% | 9% | 10% | +6 points |
| Decreased appetite | 1% | 6% | 9% | +8 points |
| Vomiting | 3% | 6% | 8% | +5 points |
Source: the Rybelsus label (DailyMed).
Rybelsus and other GLP-1s: Heartburn compared
Each label reports the trials it covers, and those trials used different groups of people. Treat it as a rough guide.
| Medicine | Highest rate in the label | Dose group | Placebo | People in the trials |
|---|---|---|---|---|
 Foundayo | 16% | 9 mg | 4% | Adults with obesity or overweight (weight management) |
 Zepbound | 10% | 15 mg | 4% | Adults with obesity or overweight (weight management) |
 Saxenda | 9.6% | all doses | 2.7% | Adults with obesity or overweight (weight management) |
 Wegovy | 9% | 2.4 mg | 3% | Adults with obesity or overweight (weight management) |
 Mounjaro | 8% | 5 mg | 3% | Adults with type 2 diabetes |
 Victoza | 7% | 1.8 mg | 1% | Adults with type 2 diabetes |
| Byetta | 6% | all doses | 3% | Adults with type 2 diabetes |
 Trulicity | 5.8% | 1.5 mg | 2.3% | Adults with type 2 diabetes |
 Ozempic | Listed, no rate given | – | – | – |
| Rybelsus | Listed, no rate given | – | – | – |
Sources: Wegovy label (DailyMed), Mounjaro label (DailyMed), Zepbound label (DailyMed), Foundayo label (DailyMed), Trulicity label (DailyMed), Saxenda label (DailyMed), Victoza label (DailyMed), Byetta label (DailyMed).
Source: the FDA label (DailyMed).
What may explain it?
These medicines slow how quickly the stomach empties. Heartburn and indigestion may develop when food stays in the stomach longer, especially after a big or fatty meal.
Source: health.clevelandclinic.org.
Details stated in the Rybelsus label
Heartburn and indigestion appear word for word in the label:
“7 mg once daily and placebo): abdominal distension (3%, 2% and 1%), dyspepsia (0.6%, 3%, 0.6%), eructation (2%, 0.6%, 0%,), flatulence (1%, 2%, 0%), gastroesophageal”
Source: the FDA label (DailyMed).
What helps, step by step
- For now, avoid spicy and fatty foods.
- After eating, stay upright instead of lying down.
- Choose smaller meals and stop eating when you feel full. With these medicines, the stomach empties more slowly.
- Eat slowly. Your brain needs time to notice that you are full.
- Keep fatty, greasy and sugary foods to a moderate amount, as they often bring symptoms on.
- Tell your prescriber if it does not ease. Another GLP-1 may be suggested by your prescriber, who may also slow the dose increases.
Check anything from the drugstore in the GLP-1 interactions checker before you take it.
Source: health.clevelandclinic.org.